Enterprise Evidence Report · NR-REPORT-V2.0

Denmark
Neuroscience Intelligence

Denmark neuroscience evidence report: current clinical, research, institution and source-linked intelligence.

Evidence rank #19 of 50 · Data maturity A · Research score 39.9 · Data confidence 100.0 / 100 · Snapshot 2026-10-12 03:34 UTC.

⚗
125Curated trials
↗
38Recruiting trials
▦
165Publications
⌂
68Institutions

Executive interpretation

Denmark ranks #19 in the current NeuroRisk evidence-ranked market layer. This ranking summarizes indexed clinical, publication and institution evidence; it is not a probability of commercial success and not an investment recommendation.

Methodology status

Methodology NR-REPORT-V2.0. No synthetic ML confidence is presented as scientific probability. Counts and source links below are tied to the generation snapshot.

Methodology →

Leading sponsors

Hoffmann-La Roche114 recruiting
Rigshospitalet, Denmark73 recruiting
Zealand University Hospital51 recruiting
Novo Nordisk A/S42 recruiting
Aarhus University Hospital41 recruiting
University of Aarhus41 recruiting
Herlev Hospital41 recruiting
Odense University Hospital41 recruiting
Pfizer30 recruiting
Merck Sharp & Dohme LLC32 recruiting

Disease activity

Alzheimers15trials
Stroke13trials
Parkinsons10trials
Depression9trials
Epilepsy8trials
Pain Neuropathy7trials
Other Psychiatry6trials
Other Neurology4trials
Adhd4trials
Multiple Sclerosis4trials

Research institutions

Kolding HospitalOpenAlexlinked institution
Novo Nordisk FoundationOpenAlexlinked institution
Kennedy CenterOpenAlexlinked institution
Capital Region of DenmarkOpenAlexlinked institution
Statens Serum InstitutOpenAlexlinked institution
World Diabetes FoundationOpenAlexlinked institution
Danish Society of CardiologyOpenAlexlinked institution

Clinical evidence trail

NCT07741526Safety, Tolerability and Biomarker-based Efficacy of NPI-001 (AT-001) in Subjects With MCI or Alzheimer's Disease (AD)ACTIVE_NOT_RECRUITING
NCT07377214Effect of Aquatic Therapy and Subsequent Training on Veterans With PTSDNOT_YET_RECRUITING
NCT07339423AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose WeightRECRUITING
NCT07304375Effects of Exercise and Sleep on Motor Learning and Functional Abilities in Multiple SclerosisRECRUITING
NCT07262788A Feasibility Study of Optimal Non-Pharmacological Lifestyle Modifications in People With Type 2 DiabetesRECRUITING
NCT07174310A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's DiseaseRECRUITING
NCT07170150A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's DiseaseRECRUITING
NCT07140445Monitoring Neurocognitive Dysfunction and the Impact of Metabolism and Physical Capacity After Paediatric HSCTNOT_YET_RECRUITING
NCT07018713A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic MigraineRECRUITING
NCT06952504A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)RECRUITING
NCT06905587Methylphenidate in Pediatric Brain Tumor Survivors With Cancer-related FatigueRECRUITING
NCT06799403Stop for Stress - a Randomized Controlled Trial Comparing an Online and a Group-based Format of an Intervention for Work-related StressRECRUITING

Research evidence trail

PUBMEDHunger pain and its reduction; qualitative insight from people with schizophrenia on semaglutide.2026-12-31
PUBMED"It's like I'm getting my body back" - a qualitative study of the embodied aspect of personal recovery in the context of community-based exercise for young adults with severe mental illness.2026-12-31
PUBMEDFrequent readmissions after hospitalization for alcohol withdrawal: a systematic review and meta-analysis.2026-12-01
PUBMEDQuality-of-life and self-perceived inequity in people with severe mental illness: the SOFIA pilot study.2026-12-01
PUBMEDNetwork analysis of changes in post-migration stressors during treatment for refugees with PTSD.2026-12-01
PUBMEDSelf-reported versus clinician-evaluated symptom assessment and diagnosis of ICD-11 PTSD and CPTSD: a comparison between the International Trauma Interview and the International Trauma Questionnaire.2026-12-01
PUBMEDExtracellular exosome signature links hypertension and Alzheimer's disease.2026-12-01
PUBMEDImpact of diabetic peripheral neuropathy on skeletal muscle microvascular function: A blood oxygen level dependent magnetic resonance imaging study.2026-11-01
PUBMEDDiagnostic performance of magnetic resonance imaging in suspected stroke: Strengths, weaknesses, and clinical correlates.2026-11-01
PUBMEDNative structure of the therapeutic IgG4 α4β5 integrin antibody natalizumab.2026-11-01
PUBMEDChitinase-1 in cerebrospinal fluid and white matter injury in patients with progressive multiple sclerosis.2026-11-01
PUBMEDNeuroimaging predictors of cognitive benefits after virtual reality-based cognitive remediation in mood or schizophrenia spectrum disorders.2026-11-01

Sources and provenance

ClinicalTrials.gov provides NCT evidence. PubMed/NCBI and OpenAlex provide research metadata. OpenAlex links institutions. World Bank indicators are included only when an explicit source row and year exist. NeuroRisk transformations add normalization, ranking and graph connections.

Limitations

Indexed corpus counts are not guaranteed exhaustive global totals. Scores are comparative decision-support signals. This report is not medical advice, regulatory advice, patent clearance, an investment recommendation or a guarantee of outcome.